期刊文献+

血清ALP、LDH水平与乳腺癌患者复发转移的相关性 被引量:1

Correlation of Serum ALP and LDH Levels with the Recurrence and Metastasis in Patients with Breast Cancer
下载PDF
导出
摘要 目的探讨血清碱性磷酸酶(ALP)、乳酸脱氢酶(LDH)与乳腺癌患者复发转移的关系,并对其相关性进行分析。方法病例对照研究,于2016年2月至2020年1月收集中山大学孙逸仙纪念医院的79例Ⅱ~Ⅳ期乳腺癌患者的临床资料,均为女性,依据患者是否存在复发转移现象分为2组,对照组(未复发转移,40例)和观察组(复发转移,39例)。观察分析两组初诊的ALP及LDH水平及其与复发转移的相关性。结果观察组的ALP、LDH水平均较对照组高,差异有统计学意义(P<0.05);血清ALP、LDH水平与乳腺癌复发转移发生风险呈正相关性(r>0,P<0.05)。结论血清ALP、LDH水平与乳腺癌患者复发转移之间具有相关性,对通过检测其血清ALP、LDH水平变化情况,可提示乳腺癌患者是否存在复发转移,及时采取有效干预措施,以减少预后风险。 Objective To investigate the relationship of serum alkaline phosphatase(ALP)and lactate dehydrogenase(LDH)with the recurrence and metastasis in patients with breast cancer,and to analyze its correlation.Methods The case-control study was performed.The clinical data of 79 patients with stageⅡ-Ⅳbreast cancer in Sun Yat-Sen Memorial Hospital of Zhongshan University from February 2016 to January 2020 were collected,and all of them were female.The patients were divided into control group(no recurrence and metastasis,40 cases)and observation group(recurrence and metastasis,39 cases)according to whether the patients had recurrence and metastasis.The correlation of newly diagnosed ALP and LDH levels with the recurrence and metastasis in two groups was observed and analyzed.Results The levels of ALP and LDH in observation group were higher than those in control group(P<0.05);The levels of serum ALP and LDH were positively correlated with the recurrence and metastasis of breast cancer(r>0,P<0.05).Conclusion There is correlation between serum ALP and LDH levels and the recurrence and metastasis in breast cancer patients.The detection of changes in serum ALP and LDH levels can indicate whether breast cancer patients have recurrence and metastasis,and effective intervention measures should be taken in time to reduce the risk of prognosis.
作者 丁睿 吴少文 DING Rui;WU Shao-wen(Department of Laboratory Medicine,Sun Yat-Sen Memorial Hospital of Zhongshan University,Guangzhou 510000,China)
出处 《中国医药指南》 2020年第16期41-42,共2页 Guide of China Medicine
基金 广东省医学科学技术研究基金项目(A2019259) 广东省基础与应用基础研究基金自然科学基金面上项目(2020A1515010115)
关键词 乳腺癌 碱性磷酸酶 乳酸脱氢酶 复发转移 Breast cancer Alkaline phosphatase Lactate dehydrogenase Recurrence and metastasis
  • 相关文献

参考文献16

二级参考文献120

  • 1王晓春,刘运江,刘现义,李中.hMAM mRNA和CK19 mRNA联合检测乳腺癌骨髓微转移[J].中华肿瘤防治杂志,2007,14(9):676-679. 被引量:15
  • 2万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 3张敬杰,欧阳涛,万文徽,邓国仁.乳腺癌患者外周血浆中游离的肿瘤相关DNA检测及其临床价值[J].中华肿瘤杂志,2007,29(8):609-613. 被引量:6
  • 4高超,赵晶,刘德生,张敬川,季雪静,候先存.联检CA15-3、CEA、TSGF及放射性核素骨显像对乳腺癌骨转移诊断的临床意义[J].放射免疫学杂志,2007,20(6):579-580. 被引量:2
  • 5Mellissa Yong, Annette Qstergaard Jensen,Jacob Bonde Jacobsen,et al. Survival in breast cancer patients with bone metastases and skeletal- related events : a population- based cohort study in Denmark ( 1999 -2007). Breast Cancer Res Treat,2011,129:495-503.
  • 6Kim M R, Roh J L, Kim J S, et al. 18F-fluomdeoxyglucosepositron emission tomography and bone scintigraphy fordetecting bone metastases in patients with malignancies of the upper aerodigestive tract. Oral Oncol,2008,44(2) :148-152.
  • 7Soloway M S, Hardeman S W, Hickey D, et al. Stratification of patients with metastatic cancer based on extent of disease on initial bone scan. Cancer, 1988,61 ( 1 ) : 195-202.
  • 8Tao Liu , Tao Cheng , Wen Xu, et al. A meta-analysis of 18FDG- PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer. Skeletal Radiol, 2011,40:523-531.
  • 9Yang H L, Liu T, Wang X M, et al. Diagnosis of bone metastases : a meta-analysis comparing ( 18 ) FDG PET, CT, MRI and bone scintigraphy. Eur Radiol,2011,21 ( 12 ) :2604 - 2617.
  • 10Tu ranli S, Cetin A. Prognostic role of serum cancer antigen 15-3 in breast cancer patients with isolated bone metastases. Biomarkers, 2010,15(5) :418.

共引文献156

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部